Though early reports lack specific outcome information, Sherren [6] in 1906 achieved a "successful" nerve graft with improvement in outcome after use of a xenograft. In 1917, Mayo-Robson [7 ...

Using these observations as a starting point, many orthopaedic surgeons have attempted to refine the nerve grafting procedure and improve long-term results. Over a span of 10 years, 130 median ...

nerve grafting, and tendon transfers. Access to integrative medicine and supportive therapy. Comprehensive care in collaboration with the patient's primary care provider and referring physician.

The review also noted that while surgical techniques like neurolysis and nerve grafting are common, the success rates vary widely depending on the specific circumstances of the injury[1].

Axogen Inc . (NASDAQ:AXGN), a leader in the regenerative medicine industry with a market capitalization of $833 million, has reached a new 52-week high, with its stock price climbing to $18.99.

Saphenous nerve injury is a recognized complication that can occur during anterior cruciate ligament reconstruction (ACLR), particularly when harvesting grafts from the hamstring tendons.